Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury

Int J Mol Sci. 2023 Jan 28;24(3):2528. doi: 10.3390/ijms24032528.

Abstract

Spinal cord injury (SCI) is a catastrophic condition associated with significant neurological deficit and social and financial burdens. It is currently being managed symptomatically, with no real therapeutic strategies available. In recent years, a number of innovative regenerative strategies have emerged and have been continuously investigated in preclinical research and clinical trials. In the near future, several more are expected to come down the translational pipeline. Among ongoing and completed trials are those reporting the use of biomaterial scaffolds. The advancements in biomaterial technology, combined with stem cell therapy or other regenerative therapy, can now accelerate the progress of promising novel therapeutic strategies from bench to bedside. Various types of approaches to regeneration therapy for SCI have been combined with the use of supportive biomaterial scaffolds as a drug and cell delivery system to facilitate favorable cell-material interactions and the supportive effect of neuroprotection. In this review, we summarize some of the most recent insights of preclinical and clinical studies using biomaterial scaffolds in regenerative therapy for SCI and summarized the biomaterial strategies for treatment with simplified results data. One hundred and sixty-eight articles were selected in the present review, in which we focused on biomaterial scaffolds. We conducted our search of articles using PubMed and Medline, a medical database. We used a combination of "Spinal cord injury" and ["Biomaterial", or "Scaffold"] as search terms and searched articles published up until 30 April 2022. Successful future therapies will require these biomaterial scaffolds and other synergistic approaches to address the persistent barriers to regeneration, including glial scarring, the loss of a structural framework, and biocompatibility. This database could serve as a benchmark to progress in future clinical trials for SCI using biomaterial scaffolds.

Keywords: biomaterial; combination therapy; regenerative medicine; scaffold; spinal cord injury.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials* / chemistry
  • Biocompatible Materials* / therapeutic use
  • Humans
  • Spinal Cord
  • Spinal Cord Injuries* / therapy
  • Stem Cell Transplantation
  • Tissue Scaffolds / chemistry

Substances

  • Biocompatible Materials